2019
DOI: 10.1007/s00213-019-05225-z
|View full text |Cite|
|
Sign up to set email alerts
|

Effects of combined escitalopram and aripiprazole in rats: role of the 5-HT1a receptor

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2020
2020
2022
2022

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(1 citation statement)
references
References 46 publications
0
1
0
Order By: Relevance
“…The pharmacological effect of escitalopram in humans is associated with an increase of the serotonin within synaptic cleft. The downregulation of 5-HT2A receptors results in the stimulation of postsynaptic 5-HT1 receptors, which is responsible for the anxiolytic and antidepressant effects of the drug [16,17]. SSRI-related changes in energy homeostasis and weight gain are often clinically observed [18], however little is known about stress-related peptidergic neuronal pathways which could be additional targets for these medications..…”
Section: Introductionmentioning
confidence: 99%
“…The pharmacological effect of escitalopram in humans is associated with an increase of the serotonin within synaptic cleft. The downregulation of 5-HT2A receptors results in the stimulation of postsynaptic 5-HT1 receptors, which is responsible for the anxiolytic and antidepressant effects of the drug [16,17]. SSRI-related changes in energy homeostasis and weight gain are often clinically observed [18], however little is known about stress-related peptidergic neuronal pathways which could be additional targets for these medications..…”
Section: Introductionmentioning
confidence: 99%